Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2041 of 6351
-
Could a smartphone app close the gap in cervical cancer Follow-Up?
Knowledge-focused CompletedIn this study, the researchers will utilize information gained from patient interviews about their knowledge of the cervical cancer screening and treatment process, and perceived barriers surrounding appropriate follow up, to create content for the intervention.
Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Could an extra year of Low-Dose steroids keep vasculitis at bay?
Disease control Recruiting nowImmunosuppressive therapy of granulomatosis with polyangiitis (GPA, Wegener's) and microscopic polyangiitis (MPA) has transformed the outcome from death to a strong likelihood of disease control and temporary remission. However, most patients have recurrent relapses that lead to …
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 17:13 UTC
-
New 5-Dose radiation approach could simplify breast cancer treatment
Disease control Recruiting nowThis study offers 5 fractions of radiation treatment through partial breast irradiation in patients with early stage breast cancer after having a lumpectomy.
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Shocking migraine away: nerve zap plus stress relief shows promise
Symptom relief CompletedThis study design has two components: 1) a cross-sectional assessment of brain activity and inflammation in migraine patients compared to healthy controls and 2) an assessment of 8 weeks of a combination therapy approach to treating migraine.
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New MRI method may end guesswork for brain tumor patients after radiation
Diagnosis Recruiting nowThis research study is investigating the value of an imaging study of the brain called an MRI (which stands for magnetic resonance imaging), utilized in unique way, to delineate whether the tumor has recurred or whether radiation changes have occurred after a brain metastasis tre…
Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Sep 10, 2026 01:00 UTC
-
Could one month of blood thinners be enough after a heart attack stent?
Disease control OngoingProspective, multicenter, randomized, double-blind, placebo-controlled trials.
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Supercharged immune cells take on Hard-to-Treat prostate cancer
Disease control OngoingThis phase I trial studies side effects and best dose of PSCA-chimeric antigen receptor (CAR) T cells in treating patients with prostate stem cell antigen positive (PSCA+) castration resistant prostate cancer that has spread to other places in the body (metastatic). PSCA-CAR T ce…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can a chicory fiber ease toddler constipation?
Disease control CompletedThe aim of the study is to confirm the effectiveness of chicory-derived prebiotic inulin-type fructans on bowel function in young children.
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug cocktail aims to outsmart relapsed leukemia
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of ruxolitinib when given together with venetoclax and compares the effect of ruxolitinib in combination with venetoclax to venetoclax and azacitidine in treating patients with acute myeloid leukemia (AML) that has come ba…
Phase 1 • Sponsor: Jennifer Saultz • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New computer model could predict best surgery for kids with sleep apnea
Knowledge-focused Recruiting nowTo create a validated computational tool to predict surgical outcomes for pediatric patients with obstructive sleep apnea (OSA). The first line of treatment for children with OSA is to remove their tonsils and adenoids; however, these surgeries do not always cure the patient. Ano…
Phase 4 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Could a pill slow down metastatic breast cancer?
Disease control OngoingThis is a single arm, open-label, lead in phase Ib dose confirmation, followed by phase II study with 2 parallel study cohorts.
Phase 1/2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can brain wiring predict which kids benefit most from reading tutoring?
Knowledge-focused By invitation onlyDespite the fact that a substantial number of school age children struggle with both reading and math acquisition, the brain mechanisms of the overlapping aspects of reading and math skills, thought in part to be linked via executive functions (EF), have not been unpacked. This p…
Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New hope for ulcerative colitis sufferers: experimental drug shows promise
Disease control CompletedPhase 2b study to evaluate the efficacy and the safety of 3 dose-levels of ABX464, administered daily in patients with moderate to severe Ulcerative Colitis.
Phase 2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug combo shows promise for rare ovarian cancer
Disease control OngoingThe goal of this clinical research study is to learn if fulvestrant and abemaciclib can help to control low-grade serous ovarian cancer. The safety of this drug combination will also be studied. This is an investigational study. Fulvestrant and abemaciclib are both FDA approved …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug shows promise for Long-Term psoriatic arthritis control
Disease control CompletedThis is a study to assess the long-term safety, long-term efficacy and tolerability of bimekizumab administered subcutaneously (sc) in adult subjects with psoriatic arthritis (PsA).
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control OngoingThis is a phase I/II, open-label, dose-escalation study designed to evaluate the safety, tolerability, and efficacy of englumafusp alfa (RO7227166) in participants with relapsed/refractory Non-Hodgkin's Lymphoma (r/r NHL). Englumafusp alfa will be administered by intravenous (IV)…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Blood Thinner's safety in frail hearts put to the test
Disease control CompletedAtrial fibrillation (AF) is the most common arrhythmia, and its prevalence is increasing with the aging population \[1\]. As the prevalence of AF is significantly rising among the population over 70-80 years old and considering the population is at high risk of AF complications s…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New therapy aims to heal Veterans' moral wounds from war
Symptom relief CompletedThe objective of this project is to test the efficacy of an individual treatment for post-traumatic stress disorder (PTSD) stemming from moral injury called Impact of Killing (IOK), compared to a present-centered therapy (PCT) control condition, and to determine the rehabilitativ…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Psoriasis drug deucravacitinib tested for Long-Term safety and vaccine response
Disease control OngoingThe main purpose of this study is to evaluate the long-term safety and efficacy of the drug Deucravacitinib (BMS-986165) in participants who have been previously enrolled in an applicable Phase 3 psoriasis study. In addition, the study includes a vaccine cohort to evaluate whethe…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Fish oil infusion may ease lung pressure in fragile newborns
Disease control By invitation onlyThe purpose of this study is to evaluate the effect of a parenteral emulsion containing n-3 long-chain polyunsaturated fatty acids (LC-PUFA) in fish oil on clinical outcomes, markers of inflammation and oxidative stress, and pain in neonates with persistent pulmonary hypertension…
Phase 2 • Sponsor: Coordinación de Investigación en Salud, Mexico • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC